The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark.

PubWeight™: 2.16‹?› | Rank: Top 2%

🔗 View Article (PMID 25684441)

Published in Aliment Pharmacol Ther on February 12, 2015

Authors

E S Dellon1, R Erichsen, J A Baron, N J Shaheen, M Vyberg, H T Sorensen, L Pedersen

Author Affiliations

1: Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Articles citing this

Seasonal variation in detection of oesophageal eosinophilia and eosinophilic oesophagitis. Aliment Pharmacol Ther (2015) 1.99

Outcomes of Esophageal Dilation in Eosinophilic Esophagitis: Safety, Efficacy, and Persistence of the Fibrostenotic Phenotype. Am J Gastroenterol (2016) 1.61

Advances in clinical management of eosinophilic esophagitis. Gastroenterology (2014) 1.48

Letter: increasing incidence and prevalence of eosinophilic oesophagitis. Aliment Pharmacol Ther (2015) 1.07

Prospective assessment of serum periostin as a biomarker for diagnosis and monitoring of eosinophilic oesophagitis. Aliment Pharmacol Ther (2016) 0.77

Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update. Curr Gastroenterol Rep (2015) 0.75

Causes and Outcomes of Esophageal Perforation in Eosinophilic Esophagitis. J Clin Gastroenterol (2016) 0.75

Environmental and infectious factors in eosinophilic esophagitis. Best Pract Res Clin Gastroenterol (2015) 0.75

Eosinophilic esophagitis in an octogenarian: A case report and review of the literature. Medicine (Baltimore) (2016) 0.75

Letter: increasing incidence and prevalence of eosinophilic oesophagitis - author's reply. Aliment Pharmacol Ther (2015) 0.75

Determination of esophageal eosinophil counts and other histologic features of eosinophilic esophagitis by pathology trainees is highly accurate. Hum Pathol (2016) 0.75

Established and Emerging Eosinophilic Gastrointestinal Diseases (EGIDs): Seeing Red and Looking Ahead. Dig Dis Sci (2016) 0.75

Management of refractory eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2017) 0.75

Articles cited by this

The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull (1999) 14.29

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology (2007) 9.05

Epidemiology. When an entire country is a cohort. Science (2000) 7.93

Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology (2003) 5.36

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol (2013) 5.09

Eosinophilic esophagitis. N Engl J Med (2004) 4.43

The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol (2014) 4.30

Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol (2005) 3.34

Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci (1993) 3.18

Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol (2007) 2.94

Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol (2008) 2.63

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55

Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2009) 2.53

Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol (2013) 2.25

Prevalence and predictive factors of eosinophilic esophagitis in patients presenting with dysphagia: a prospective study. Am J Gastroenterol (2007) 2.14

Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol (2011) 2.07

Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol (2010) 2.00

Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol (2013) 1.75

Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank. Clin Epidemiol (2010) 1.66

The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol (2012) 1.64

Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child (2006) 1.53

Eosinophilic oesophagitis in patients presenting with dysphagia--a prospective analysis. Aliment Pharmacol Ther (2008) 1.49

Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am (2014) 1.46

The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther (2013) 1.45

Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil (2012) 1.22

Epidemiology. The epidemiologist's dream: Denmark. Science (2003) 1.20

Eosinophilic esophagitis disease in children from West Virginia: a review of the last decade (1995-2004). Am J Gastroenterol (2007) 1.17

Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009. World J Gastroenterol (2012) 1.09

Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther (2010) 1.07

Review article: oesophageal dilation in adults with eosinophilic oesophagitis. Aliment Pharmacol Ther (2011) 1.07

Practice patterns for the evaluation and treatment of eosinophilic oesophagitis. Aliment Pharmacol Ther (2010) 1.05

The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study. Aliment Pharmacol Ther (2012) 1.00

Eosinophilic esophagitis: from rookie of the year to household name. Clin Gastroenterol Hepatol (2008) 0.99

Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment Pharmacol Ther (2013) 0.97

The diagnosis of primary eosinophilic oesophagitis in adults: missed or misinterpreted? Eur J Gastroenterol Hepatol (2010) 0.96

Eosinophilic oesophagitis in infants and children in the region of southern Denmark: a prospective study of prevalence and clinical presentation. J Pediatr Gastroenterol Nutr (2010) 0.94

Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol (2013) 0.91

Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis. Aliment Pharmacol Ther (2013) 0.85

Are pathologists accurately diagnosing eosinophilic esophagitis in children? A 9-year single academic institutional experience with interobserver observations. Int J Surg Pathol (2010) 0.82

Development and validation of a registry-based definition of eosinophilic esophagitis in Denmark. World J Gastroenterol (2013) 0.81

Articles by these authors

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16

Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am (2001) 7.67

The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health (1992) 6.97

A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med (1994) 5.98

The framing effect of relative and absolute risk. J Gen Intern Med (1993) 4.87

Prognosis of cancers associated with venous thromboembolism. N Engl J Med (2000) 4.51

Ethics of a prostate cancer screening trial. Lancet (1994) 4.21

Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ (2001) 3.73

Capitation, salary, fee-for-service and mixed systems of payment: effects on the behaviour of primary care physicians. Cochrane Database Syst Rev (2000) 3.46

Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients. Aliment Pharmacol Ther (2014) 3.37

Heterogeneity of hip fracture: age, race, sex, and geographic patterns of femoral neck and trochanteric fractures among the US elderly. Am J Epidemiol (1996) 3.16

Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum (1997) 2.93

New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations. Structure (1999) 2.92

Impact of payment method on behaviour of primary care physicians: a systematic review. J Health Serv Res Policy (2001) 2.67

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43

Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states. N Engl J Med (1988) 2.33

Hip fracture incidence and mortality in New England. Epidemiology (1991) 2.32

Smoking and estrogen-related disease. Am J Epidemiol (1984) 2.31

How should we pay doctors? A systematic review of salary payments and their effect on doctor behaviour. QJM (1999) 2.26

Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect (1998) 2.22

Jewish religion and risk of breast cancer. Lancet (1996) 2.14

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med (1990) 2.13

Idiopathic bile acid catharsis. Gut (1976) 2.11

Pregnancy outcome following prescription for sumatriptan. Headache (2000) 2.06

Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol (2014) 2.04

Chronic liver disease and 90-day mortality in 21,359 patients following peptic ulcer bleeding--a Nationwide Cohort Study. Aliment Pharmacol Ther (2015) 2.01

Use of systemic glucocorticoids and the risk of colorectal cancer. Aliment Pharmacol Ther (2012) 2.00

Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol (1996) 1.98

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98

Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology (2001) 1.96

The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med (1994) 1.96

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost (2009) 1.95

Does the medical record cover the symptoms experienced by cancer patients receiving palliative care? A comparison of the record and patient self-rating. J Pain Symptom Manage (2001) 1.91

Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost (2007) 1.89

Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health (1990) 1.88

Treatment and survival among elderly Americans with hip fractures: a population-based study. Am J Public Health (1994) 1.83

Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction . Ann Intern Med (1990) 1.82

Structural basis for nucleotide exchange and competition with tRNA in the yeast elongation factor complex eEF1A:eEF1Balpha. Mol Cell (2000) 1.78

Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73

Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med (2010) 1.71

Long-term effects of migraine on cognitive function: a population-based study of Danish twins. Neurology (2005) 1.65

The quality of care in Barrett's esophagus: endoscopist and pathologist practices. Am J Gastroenterol (2001) 1.63

Crystal structures of nucleotide exchange intermediates in the eEF1A-eEF1Balpha complex. Nat Struct Biol (2001) 1.62

Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control (2000) 1.61

Target payments in primary care: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2000) 1.59

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation. Aliment Pharmacol Ther (2011) 1.58

Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group. JAMA (1992) 1.57

Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control (2000) 1.56

Oral-contraceptive use and risk of hip fracture: a case-control study. Lancet (1999) 1.53

Influences of solvent water on protein folding: free energies of solvation of cis and trans peptides are nearly identical. Biochemistry (1988) 1.51

Occupational exposure to 60-hertz magnetic fields and risk of breast cancer in women. Epidemiology (1996) 1.51

Fracture risk in the U.S. Medicare population. J Clin Epidemiol (1999) 1.49

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group. BMJ (1998) 1.48

Sigmoidoscopy costs and the limits of altruism. Am J Med (1999) 1.45

Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44

Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology (2001) 1.43

Birth outcomes in women exposed to anticonvulsant drugs. Acta Neurol Scand (2000) 1.43

Association of adiponectin multimers with Barrett's oesophagus. Gut (2009) 1.43

Cancer staging may have different meanings in academic and community hospitals. J Clin Epidemiol (1991) 1.43

Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice. J Intern Med (2002) 1.43

Use of oral contraceptives and endometrial cancer risk (Sweden). Cancer Causes Control (1999) 1.42

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers. Br J Cancer (2013) 1.41

Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology (1998) 1.40

Left-handedness in relation to breast cancer risk in postmenopausal women. Epidemiology (2000) 1.40

Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Dis (2006) 1.39

Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer (2001) 1.37

Cancer risk and mortality in users of calcium channel blockers. A cohort study. Cancer (2000) 1.36

Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study. Pain (1990) 1.34

A randomized controlled trial of low carbohydrate and low fat/high fiber diets for weight loss. Am J Public Health (1986) 1.33

Cigarette smoking and Parkinson's disease. Neurology (1986) 1.33

Rapid screening of increased bile acid deconjugation and bile acid malabsorption by means of the glycine-l-(14C) cholylglycine assay. Scand J Gastroenterol (1973) 1.33

Genital talc exposure and risk of ovarian cancer. Int J Cancer (1999) 1.31

Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol (2002) 1.29

Sequence and genetic analysis of the hemin storage (hms) system of Yersinia pestis. Gene (1997) 1.26

Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst (1993) 1.26

Improvement of drug exposure data in a registration of congenital anomalies. Pilot-study: pharmacist and mother as sources for drug exposure data during pregnancy. EuroMAP Group. Europen Medicine and Pregnancy Group. Teratology (1999) 1.26

Diarrhoea associated with idiopathic bile acid malabsorption. Fact or fantasy? Dan Med Bull (1973) 1.25

Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control (2002) 1.23

Cigarette smoking in women with cancers of the breast and reproductive organs. J Natl Cancer Inst (1986) 1.22

Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer (2008) 1.22

Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer (2005) 1.22

Fracture history and risk of breast and endometrial cancer. Am J Epidemiol (2001) 1.22

Exposure to breast milk in infancy and adult breast cancer risk. J Natl Cancer Inst (1998) 1.22

Visual, auditory and somatosensory pathway involvement in hereditary cerebellar ataxia, Friedreich's ataxia and familial spastic paraplegia. Electroencephalogr Clin Neurophysiol (1981) 1.21

Clinical trials: healing of erosive oesophagitis with dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed-release formulation--results from two randomized controlled studies. Aliment Pharmacol Ther (2009) 1.19

Cigarette smoking and the risk of natural menopause. Epidemiology (1990) 1.18

Short- and long-term mortality following primary total hip replacement for osteoarthritis: a Danish nationwide epidemiological study. J Bone Joint Surg Br (2011) 1.17

Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst (1996) 1.17

Cigarette smoking and steroid hormones in women. J Steroid Biochem Mol Biol (1991) 1.16

A linkage study of hereditary ataxias and related disorders. Evidence of heterogeneity of dominant cerebellar ataxia. Hum Genet (1980) 1.14

Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med (2009) 1.14

Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy (2007) 1.14

Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer (2010) 1.14

Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. Oncogene (2000) 1.13

Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis (2000) 1.13

Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am (2010) 1.13

Effect of seasonality and weather on fracture risk in individuals 65 years and older. Osteoporos Int (2007) 1.13

The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years. Int J Cancer (1999) 1.12

Lactation in relation to postmenopausal breast cancer. Am J Epidemiol (1999) 1.11